• In this retrospective study, 72 patients with colorectal cancer were followed up for a mean period of 28.2 months. (who.int)
  • Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump. (nih.gov)
  • Colorectal carcinoma (CRC) represents the 3rd most commonly diagnosed cancer in men and second in women, with more than 1.2 million new cancer cases and 600 000 deaths only in 2008. (umfcv.ro)
  • A recent hypothesis is based on a direct relationship between angiogenesis and colorectal cancer stem cells (CR-CSCs) proliferation, this interaction being the cornerstone of initial response encountered during biological treatment. (umfcv.ro)
  • Most cases of colorectal cancer in adolescents and young adults are sporadic, but several genetic syndromes are associated with these tumors in young patients. (medscape.com)
  • Surgical treatment of metastatic colorectal cancer offers a chance for cure or prolonged survival. (medscape.com)
  • Colorectal cancer (CRC) is the most common cancer of the gastrointestinal (GI) tract. (medscape.com)
  • The aim of the present study was to describe treatment outcomes for bevacizumab in combination with chemotherapy based on data from the Czech registry of targeted therapies for metastatic colorectal cancer (mCRC). (iiarjournals.org)
  • Colorectal cancer (CRC) is one of the most common types of cancers in the developed world. (iiarjournals.org)
  • The data for this retrospective analysis were obtained from the national registry of patients treated with targeted agents for colorectal cancer. (iiarjournals.org)
  • Patients treated for colorectal cancer at the UPTH over a 19- year period (1987-2006) and had complete information, were studied. (bvsalud.org)
  • 1994. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer pa tients. (cdc.gov)
  • 1998. Inci dence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. (cdc.gov)
  • Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer. (cdc.gov)
  • Evaluation of a counseling protocol for predictive genetic testing for hereditary non-polyposis colorectal cancer. (cdc.gov)
  • Do NSAIDs prevent colorectal cancer? (cdc.gov)
  • 1999. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. (cdc.gov)
  • Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. (cdc.gov)
  • 2000. Microsatel lite instability in colorectal-cancer patients with suspected genetic predisposition. (cdc.gov)
  • In this study, we investigated the factors that may determine the likelihood of additional regional lymph node metastasis when metastasis is found in nodes at the N1 site in colorectal cancer, especially focusing on the presence of ECI. (biomedcentral.com)
  • Thus, the purpose of this study was to investigate the correlation between the presence of ECI of positive lymph nodes at the N1 site and nodal metastasis at the N2 site in cases with resectable colorectal cancer. (biomedcentral.com)
  • Immune-based approaches in colorectal cancer have unfortunately with the notable exception of immune checkpoint inhibition in microsatellite instable (MSI-hi) disease been largely unsuccessful. (nih.gov)
  • To determine the safety, tolerability and feasibility of Pexa-Vec oncolytic virus in combination with immune checkpoint inhibition in patients with refractory metastatic colorectal cancer. (nih.gov)
  • Histologically confirmed metastatic colorectal cancer. (nih.gov)
  • The proposed study is Phase I/II study of Pexa-Vec oncolytic virus at two dose levels in combination with immune checkpoint inhibition in patients with metastatic colorectal cancer. (nih.gov)
  • Therefore, targeting of both the COX-2 and ErbB signaling pathways may represent a novel approach for the treatment and/or prevention of colorectal cancer in humans. (elsevierpure.com)
  • 1. Methyl-CCNU, 6-thioguanine, and 5-fluorouracil in advanced colorectal cancer. (nih.gov)
  • 2. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study. (nih.gov)
  • 3. Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer. (nih.gov)
  • 6. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764). (nih.gov)
  • 7. Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine. (nih.gov)
  • 8. Treatment of advanced colorectal cancer with a combination of 5-fluorouracil and methyl-CCNU. (nih.gov)
  • 9. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu). (nih.gov)
  • 10. Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion. (nih.gov)
  • 11. Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea. (nih.gov)
  • 15. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer. (nih.gov)
  • In India, colon cancer ranks thirteen among new cases as well as in terms of deaths while rectal carcinoma ranks sixteenth among new cases and fifteenth among death. (ijmrhs.com)
  • Excellent screening modalities and treatment is available for colorectal cancer and remains underutilized. (ijmrhs.com)
  • Symptoms, initial diagnosis, and treatment are similar to other forms of colorectal cancer. (msdmanuals.com)
  • Colorectal Cancer Colorectal cancer is extremely common. (msdmanuals.com)
  • Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis. (nih.gov)
  • BACKGROUND: Nonsteroidal anti-inflammatory drug (NSAID) use has been associated with a decreased colorectal cancer (CRC) risk. (nih.gov)
  • ABSTRACT This study aimed to identify the status of 2 major microsatellite instability markers (repair genes hMSH2 and hMSH6) in colorectal cancer cases operated at King Khalid University Hospital, Riyadh, Saudi Arabia between 2007 and 2009. (who.int)
  • Further studies are needed to confirm the use of these markers in the diagnosis of colorectal cancer. (who.int)
  • Des études supplémentaires sont nécessaires pour confirmer l'utilisation de ces marqueurs dans le diagnostic du cancer colorectal. (who.int)
  • If you've been diagnosed with colorectal cancer, your cancer care team will discuss your treatment options with you. (cancer.org)
  • Colorectal cancer can also be treated using drugs, which can be given by mouth or directly into the bloodstream. (cancer.org)
  • Who treats colorectal cancer? (cancer.org)
  • Background: The bevacizumab-cetuximab combination has shown promising activity in chemotherapy-refractory metastatic colorectal cancer (mCRC). (elsevierpure.com)
  • Clinical colorectal cancer , 9 (5), 290-296. (elsevierpure.com)
  • Colorectal cancer (CRC) is the second most prevalent cancer worldwide, and in 35% of cases it is an inherited form. (fapvoice.com)
  • MAP is a hereditary colorectal cancer syndrome inherited in an autosomal-recessive fashion. (fapvoice.com)
  • Association Between the Age and the Development of Colorectal Cancer in Patients with Familial Adenomatous Polyposis. (fapvoice.com)
  • The principles of screening were drafted in 1968: for colorectal cancer, they comprise the secondary prevention method. (ceu-jgh.org)
  • Increased Free Circulating DNA Integrity Index as a Serum Biomarker in Patients with Colorectal Carcinoma', Asian Pacific Journal of Cancer Prevention , 17(3), pp. 939-944. (waocp.org)
  • Monoclonal antibodies directed against the EGF-receptor (EGFR) have recently been approved for the treatment of metastatic colorectal cancer (CRC) patients with EGFR-positive tumors at immunohistochemistry (IHC). (unicampus.it)
  • Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. (nature.com)
  • Bevacizumab, a VEGF-A inhibitor, in combina- tion with chemotherapy, has proven to increase progression- free survival (PFS) and overall survival in multiple lines of therapy of metastatic colorectal cancer (mCRC). (elsevierpure.com)
  • Colorectal carcinoma is the fourth most frequent cancer in men after prostate and lung or bronchus cancers whereas in women is the third most frequent cancer after breast and lung or bronchus cancers. (isainsmedis.id)
  • Colorectal cancer is a leading cause of cancer death worldwide, accounting for 693,900 deaths in 2012 and is the fourth most frequent cancer in men whereas in women is the third most frequent cancer. (isainsmedis.id)
  • Bhandari, A., Woodhouse, M., and Gupta, S. Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: a SEER-based analysis with comparison to other young-onset cancers. (isainsmedis.id)
  • Accuracy of preoperative local staging of primary colorectal cancer by using computed tomography: reappraisal based on data collected at a highly organized cancer center. (pakjr.com)
  • Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT. (pakjr.com)
  • Liang C, Huang Y, He L, Chen X, Ma Z, Dong D, Tian J, Liang C, Liu Z. The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer. (pakjr.com)
  • Background Breast cancer (BC) and colorectal cancer (CRC) are considered primary cancers that affect both male and females globally. (medrxiv.org)
  • As reported by recent Malaysian National Cancer Registry (MNCR), the five most prevalent cancers among both males and females are breast, colorectal, trachea, bronchus and lung and lymphoma and nasopharynx cancer ( 3 ). (medrxiv.org)
  • According to the statistics on causes of death 2019, both colorectal cancer (CRC) and breast cancer (BC) were ranked as the ninth and tenth leading cause of medically certified deaths in Malaysia ( 4 ). (medrxiv.org)
  • Growth promotion of colorectal cancer by mesenchymal stromal cells - when and how? (uib.no)
  • nonetheless, the incidence of pediatric colorectal tumors is rising. (medscape.com)
  • Deletions of genetic material that include the DCC gene have been found in more than 70 percent of colorectal cancers, as well as other cancerous tumors. (medlineplus.gov)
  • We conclude that angiogenesis and p53 play a critical role in colorectal neoplasia, and the process of malignant transformation in tumors arising from highly angiogenic adenomas, particularly those carrying p53 mutations, is accelerated with rapid tumor progression from stage to stage, indicating a more aggressive tumor phenotype. (ox.ac.uk)
  • Of 54 colorectal carcinomas, there were 27 tumors with iNOS expression. (elsevierpure.com)
  • The proportion of tumors occurring in the rectum was significantly lower in iNOS-positive carcinomas than in iNOS-negative carcinomas (p=0.028). (elsevierpure.com)
  • reported that after curative resection, 2.3% of T1 colorectal carcinoma patients developed recurrence during the median follow-up period of 7.8 years. (medscape.com)
  • All three patients (two males and one female) were Chinese and had different sites of colorectal carcinoma with OM: rectum, sigmoid colon, and appendix. (nih.gov)
  • Fifty-one patients with metastatic colorectal carcinoma confined to the liver received intraarterial chemotherapy through the hepatic artery via a subcutaneous pump. (nih.gov)
  • However, the mechanism of metastatic spreading of tumor cells to distant lymph nodes in patients with colorectal carcinoma is not fully understood. (biomedcentral.com)
  • Two hundred and twenty-eight consecutive patients who underwent colorectal resection were identified for inclusion in this study, of which 37 (16.2%) had positive lymph nodes at the N1 site. (biomedcentral.com)
  • However, little is known about the mechanism or process of metastatic spreading of tumor cells to distant regional lymph nodes in patients with colorectal carcinoma with positive lymph nodes. (biomedcentral.com)
  • Two hundred and twenty-eight consecutive patients who underwent colorectal resection in the Department of General Surgical Science, Graduate School of Medicine, Gunma University, from January 2007 to December 2009 were identified for inclusion in this study. (biomedcentral.com)
  • Patients must have histopathological confirmation of Colorectal Carcinoma (CRC) by the Laboratory of Pathology of the NCI prior to entering this study. (nih.gov)
  • 14. [A clinical study (phase II) of a combination of 5-fluorouracil, vincristine and methyl CCNU in patients with advanced carcinoma of the large intestine]. (nih.gov)
  • Five patients with advanced colorectal and gastric carcinoma with peritoneal deposits were treated by continuous weekdays intraperitoneal (i.p.) instillation of 5-fluorouracil (5-FU) 200 mg m-2 day-1 in a novel dialysate solution that ensures maximal exposure of peritoneal areas liable to bear tumours for 24 h. (ox.ac.uk)
  • The subjects were the 54 patients with colorectal carcinoma, including 13 with obstructing carcinoma. (elsevierpure.com)
  • Twelve patients were infused with radiolabelled huA33 at 7 days prior to elective surgery for colorectal carcinoma. (springeropen.com)
  • In patients with colorectal carcinoma, monoclonal antibody huA33 effectively targets viable tumour cells in all cellular milieus examined, including effective penetration into necrotic tumour centres, a novel and therapeutically important finding. (springeropen.com)
  • ABSTRACT:Objective: To determine the correlation of contrast enhanced computed tomography in TNM staging system of colo-rectal carcinoma with histopathology in preoperative patients for establishing the treatment and predicting the prognosis.Introduction: Colorectal carcinoma most common malignancy of gastrointestinal tract. (pakjr.com)
  • Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. (nih.gov)
  • Heme oxygenase-1 promotes tumor progression and metastasis of colorectal carcinoma cells by inhibiting antitumor immunity. (bvsalud.org)
  • These findings imply the possibility that ECI might indicate the ability of colorectal tumor cells to disseminate to distant lymph nodes. (biomedcentral.com)
  • Mutations of p53 tumor suppressor gene are frequent and play an important role in colorectal oncogenesis. (ox.ac.uk)
  • Cho, S.-J. & Kakar, S. Tumor budding in colorectal carcinoma: translating a morphologic score into clinically meaningful results. (nature.com)
  • Colorectal carcinoma (CRC) is a disease in which epithelial cells in the colon or rectum become abnormal and divide without control, forming a mass called a tumor. (isainsmedis.id)
  • Mehlen P, Llambi F. Role of netrin-1 and netrin-1 dependence receptors in colorectal cancers. (medlineplus.gov)
  • Colorectal carcinomas are usually cancers of old age but nowadays there has been a steady increase of colorectal carcinoma among young adults. (ijmrhs.com)
  • This parallels the assignment of the FAP gene to chromosome 5 (see accompanying paper) and suggests that becoming recessive for this gene may be a critical step in the progression of a relatively high proportion of colorectal cancers. (ox.ac.uk)
  • The retinoblastoma (Rb) gene is inactivated in a variety of human cancers, but in colorectal carcinomas there is frequently increased expression of this gene. (tau.ac.il)
  • This was a biopsy proven metastasis of colorectal carcinoma, which was subsequently resected. (mudr.org)
  • This study was designed to confirm the high prevalence of OSA in human malignancies and assess its prognostic relevance in metastatic colorectal carcinomas (mCRCs). (unifg.it)
  • The main mechanism emphasized in colorectal carcinogenesis is the adenoma-carcinoma sequence. (eastjmed.org)
  • Angiogenesis and p53 expression in the colorectal adenoma-carcinoma sequence. (ox.ac.uk)
  • Extensive microsatellite instability (MSI-high) is characteristic of colorectal carcinomas in hereditary nonpolyposis colorectal carcinoma (HNPCC) and in 10-% 15% of sporadic colorectal carcinomas. (nih.gov)
  • We evaluated angiogenesis and p53 expression in 16 hyperplastic polyps, 35 solitary tubular and tubulovillous adenomas, and 47 cases of sporadic colorectal carcinomas arising on the basis of preexisting adenomas, with standard immunohistochemical techniques. (ox.ac.uk)
  • Following a clue as to the location of the FAP gene given by a case report of an individual with an interstitial deletion of chromosome 5q, who had FAP and multiple developmental abnormalities, we have examined sporadic colorectal adenocarcinomas for loss of alleles on chromosome 5. (ox.ac.uk)
  • The dominantly inherited disorder, familial adenomatous polyposis (FAP, also called familial polyposis coli), which gives rise to multiple adenomatous polyps in the colon that have a relatively high probability of progressing to a malignant adenocarcinoma, provides a basis for studying recessive genes in the far more common colorectal carcinomas using this approach. (ox.ac.uk)
  • 50 years, men had a higher risk to get colorectal carcinoma, adenocarcinoma is the most common microscopic type, and rectum was the most common site of colorectal carcinoma. (isainsmedis.id)
  • The primary objectives are to assess the effect of statins on the incidence of colorectal adenomatous polyps and on the incidence of CRC compared with placebo. (cochrane.org)
  • The incidence of lymph node metastasis and lymphatic invasion in colorectal carcinomas with iNOS expression (63.0%, 17 out of 27 and 96.3%, 26 out of 27, respectively) were significantly more frequent than those in carcinomas without iNOS expression (29.6%, 8 out of 27 and 70.4%, 19 out of 27, respectively) (p=0.013 and p=0.011, respectively). (elsevierpure.com)
  • The incidence of pRb-positive cells was increased during multistage colorectal carcinogenesis. (tau.ac.il)
  • Here, we report three cases of colorectal carcinoma with OM and propose a new hypothesis. (nih.gov)
  • 4. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273). (nih.gov)
  • Conclusion: Multi-detector CT scan with rectal oral and IV contrast has good accuracy in diagnosis of colorectal carcinoma beyond the bowel wall with loco-regional extension. (pakjr.com)
  • squamous cell carcinoma in the first rectal fold. (cancer.org)
  • Colorectal carcinoma , the commonest malignant tumour of the gastrointestinal tract , is rather uncommon in Nigeria , occurring often at a relatively early age. (bvsalud.org)
  • All non-malignant colorectal pathologies and carcinoma of anus were excluded. (ijmrhs.com)
  • Our results could suggest that iNOS expression can be an indicator of malignant potential in colorectal carcinoma and that it may be one of the biological features of obstructing carcinoma of the colon and rectum. (elsevierpure.com)
  • Familial Adenomatous Polyposis Familial adenomatous polyposis is a hereditary disorder causing numerous colonic polyps and frequently results in colon carcinoma, often by age 40. (msdmanuals.com)
  • Often, polyps progress to colorectal carcinomas later in life. (jax.org)
  • Aims-Chromosomal gains and losses were surveyed by comparative genomic hybridisation (CGH) in a series of colorectal adenomas and carcinomas, in search of high risk genomic changes involved in colorectal carcinogenesis. (johnshopkins.edu)
  • abstract = "Significance of expression of cytokine induced nitric oxide synthase (iNOS) in colorectal carcinoma remains controversial. (elsevierpure.com)
  • Lymph node status is one of the most important prognostic factors for colorectal carcinoma. (biomedcentral.com)
  • Colorectal carcinoma (CRC) constitutes a common malignancy with limited therapeutic options in metastasized stages. (uib.no)
  • Linear regression analysis of MVD between cancerous and adenomatous areas showed a significant correlation (P = 0.0001, r = 0.56), raising the possibility that carcinomas arising from better vascularized adenomas might show increased vascularity. (ox.ac.uk)
  • All 25 HNPCC colorectal carcinomas were MSI-high. (nih.gov)
  • In the event that critical pathologic changes are observed upon endoscopic resection for a T1 colorectal carcinoma, there is concern about whether follow-up observations should be performed or additional surgical resection should be carried out. (medscape.com)
  • Microsatellite instability-high colorectal carcinomas differ from others in important clinical and pathologic features. (nih.gov)
  • The presence of MSI defines a subset of colorectal carcinomas with special molecular etiology and characteristic clinical, pathologic features, inclusive of increased survival. (nih.gov)
  • The authors evaluated TILs as a pathology screen for MSI-high status in 138 colorectal carcinomas that had been evaluated for MSI in a variety of studies. (nih.gov)
  • Gains of 13q and also of 20q and 8q seem especially to be involved in the progression of adenomas to carcinomas, possibly owing to low level overexpression of oncogenes at these loci. (johnshopkins.edu)
  • We sought to determine the effects of treatment with a specific COX-2 inhibitor and/or a monoclonal antibody against the ErbB receptor subtype HER-2/neu on carcinoma cell growth. (elsevierpure.com)
  • Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm]. (nih.gov)
  • In 2018, a new screening programme covering those aged 50 to 70 years old throughout the country was started, which will hopefully change the unfavourable morbidity and mortality of colorectal carcinoma. (ceu-jgh.org)
  • INTRODUCTION: Colorectal carcinomas are the cause of high mortality and morbidity and are common in the world and in our country. (eastjmed.org)
  • METHODS: 30 colorectal adenocarcinomas (10 well differentiated, 10 moderately differentiated, 10 poorly differentiated), 30 colon adenomas (10 tubular, 10 villous, 10 tubulovillous) and 10 normal colonic mucosa were included in our study. (eastjmed.org)
  • Methods-Nine colorectal adenomas and 14 carcinomas were analysed by CGH, and DNA ploidy was assessed with both flow and image cytometry. (johnshopkins.edu)
  • On conclusion 39 (78%) were diagnosed as same stage on multi-detector CT scan in association with histopathology and 11 (22%) were not corresponding to the stage of colorectal carcinoma on histopathology. (pakjr.com)
  • 2000. Family history-taking in community family practice: implications for genetic scre i en ng. (cdc.gov)
  • In a previous JSCCR research project, we reported mid-term outcomes of endoscopically treated submucosal invasive colorectal carcinomas that were followed up without additional surgery, and the validity of the JSCCR guideline criteria under which endoscopic resection is considered to be curative. (medscape.com)
  • When considering the necessity of additional surgical treatment after endoscopic resection for submucosal carcinoma, decisions should only be made after comprehensive comparison and consideration of the patient's individual clinical characteristics, along with the calculated risk of LN metastasis and the advantages and disadvantages of surgery. (medscape.com)
  • The aim of the current study was to elucidate the significance of immunohistochemical expression of iNOS in colorectal carcinoma. (elsevierpure.com)
  • The immunohistochemical expression of iNOS was examined and the clinicopathological data were compared between iNOS-positive and iNOS-negative carcinomas. (elsevierpure.com)
  • For this reason, complete removal of the lesion and accurate histopathologic diagnosis are essential in T1 colorectal carcinoma. (medscape.com)
  • Objectives: To measure the DNA integrity index in serum and the absolute DNA concentration to assess their clinical utility as potential serum biomarkers for colorectal carcinoma (CRC) compared to CEA and CA19-9. (waocp.org)
  • Prall, F. Tumour budding in colorectal carcinoma. (nature.com)
  • In the 14 carcinomas an average of 11.9 (range 5 to 17) events were found per tumour. (johnshopkins.edu)
  • Histopathological reports were reviewed for all colorectal carcinoma from January 2016 to December 2020 for type and staging. (ijmrhs.com)
  • This study aims to know the prevalence of colorectal carcinoma based on microscopic type, sex, age and anatomical location in Sanglah General Hospital in Denpasar from January 2014 to January 2016. (isainsmedis.id)
  • We did not detect increased systemic VEGF levels after AdsFlt1-3 treatment and liver toxicity was low as judged by serum alanine aminotransferase determination.CONCLUSION: In this study we confirmed the value of a systemic administration of AdsFlt1-3 to block VEGF signaling as antitumor therapy in an experimental metastatic colorectal carcinoma model in mice. (wanfangdata.com.cn)
  • [ 24 ] We have also previously reported that if differentiation of the submucosal invasive front is considered, complete cure by endoscopic treatment is possible for colorectal carcinomas invading the submucosa to a depth of 1500 μm but showing no vascular invasion. (medscape.com)
  • Conclusions: Combined treatment with COX-2 and HER-2/neu inhibitors more effectively reduces colorectal carcinoma growth than either agent alone. (elsevierpure.com)
  • Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma. (ox.ac.uk)
  • In this study, we aimed to determine the expression of Insulin-like growth factor II m-RNA-binding protein 3 (IMP3), which is an immune marker in colorectal carcinomas, and its relationship with prognostic factors. (eastjmed.org)